Should I buy or sell Ocean Biomedical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ocean Biomedical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OCEA shares. View OCEA analyst ratings or view top-rated stocks .

What is Ocean Biomedical's stock price target for 2024?

1 brokerages have issued twelve-month target prices for Ocean Biomedical's stock. Their OCEA share price targets range from $17.63 to $17.63. On average, they predict the company's share price to reach $17.63 in the next twelve months. This suggests a possible upside of 887.7% from the stock's current price. View analysts price targets for OCEA or view top-rated stocks among Wall Street analysts .

When did Ocean Biomedical IPO?

Ocean Biomedical (OCEA) raised $22 million in an initial public offering on the week of April 18th 2022. The company issued 2,000,000 shares at a price of $10.00-$12.00 per share. Roth Capital Partners and JonesTrading served as the underwriters for the IPO.

NASDAQ:OCEA

Ocean Biomedical (OCEA) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free OCEA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $1.66
▼
$1.80
50-Day Range: N/A
52-Week Range: N/A

Volume: 160,472 shs
Average Volume: 509,405 shs
Market Capitalization: $60.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $17.63

Stock Analysis Analyst Forecasts Competitors Headlines Options Chain Ownership Short Interest Social Media

Get Ocean Biomedical alerts:

Ocean Biomedical MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 887.7% Upside
$17.63 Price Target
Short Interest: Bearish
10.92% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.00
Based on 8 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.84 out of 5 stars

Medical Sector

595th out of 913 stocks

Pharmaceutical Preparations Industry

254th out of 396 stocks

3.5

Analyst's Opinion

Consensus Rating
Ocean Biomedical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Ocean Biomedical has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
10.92% of the float of Ocean Biomedical has been sold short.
Short Interest Ratio / Days to Cover
Ocean Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Ocean Biomedical has recently increased by 7.17%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Ocean Biomedical does not currently pay a dividend.
Dividend Growth
Ocean Biomedical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OCEA.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 8 news articles for Ocean Biomedical this week, compared to 2 articles on an average week.
Search Interest
Only 21 people have searched for OCEA on MarketBeat in the last 30 days. This is a decrease of -68% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added Ocean Biomedical to their MarketBeat watchlist in the last 30 days. This is a decrease of -44% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Ocean Biomedical insiders have not sold or bought any company stock.
Percentage Held by Insiders
73.50% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 24.55% of the stock of Ocean Biomedical is held by institutions.

N/A

Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Ocean Biomedical

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

OCEA Stock News Headlines

April 18, 2024 | msn.com

Meet the 11 global world-changers in the 2024 TED Fellows cohort

April 17, 2024 | msn.com

What’s polluting the oceans? UC San Diego to lead large study of contaminants’ source, fate and health impacts

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 16, 2024 | newsweek.com

AGW-Mental Wellbeing 2024 - Mid-size companies

April 16, 2024 | msn.com

To Help the Allied War Effort, These Scientists Got Drunk on Nitrogen

April 15, 2024 | msn.com

Stocks Rise but Gains Limited by Rising Bond Yields

April 15, 2024 | msn.com

Stocks Climb Although Iran-Israeli Tensions Remain High

April 12, 2024 | finance.yahoo.com

Apheresis Market Worth $3.9 billion | MarketsandMarkets™

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 3, 2024 | msn.com

University of Strathclyde And British Council Offer £10,000 Engineering Scholarship

April 3, 2024 | finance.yahoo.com

Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsight

April 2, 2024 | uk.news.yahoo.com

"Space debris" spotted over California skyline after rocket launch

March 28, 2024 | msn.com

Rice husk can be used as a promising sustainable packaging material

March 28, 2024 | globenewswire.com

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL

March 20, 2024 | seekingalpha.com

Ocean Biomedical: Shooting Upward, But Not Somewhere I Want To Be (Rating Upgrade)

March 20, 2024 | msn.com

For intermittent fasters, 4 protein-rich meals can help you stay full and energized on the go

March 20, 2024 | finance.yahoo.com

OCEA May 2024 7.500 call

March 20, 2024 | finance.yahoo.com

OCEA May 2024 2.500 put

March 19, 2024 | msn.com

Horseshoe crabs, prized by the biomedical industry for their blood, to get new protections in Massachusetts

March 15, 2024 | yahoo.com

Cape Cod Poetry: Have you ever read a poem aloud? If not, you are missing good stuff.

March 11, 2024 | msn.com

Empirical Research Partners 'prone to trim' chip stocks in March portfolio strategy

March 10, 2024 | finance.yahoo.com

OCEA Mar 2024 10.000 put

March 7, 2024 | finance.yahoo.com

OCEA Apr 2024 10.000 call

March 7, 2024 | finance.yahoo.com

OCEA Jul 2024 12.500 call

March 4, 2024 | finance.yahoo.com

OCEA Oct 2024 2.500 put

March 4, 2024 | finance.yahoo.com

OCEA Jul 2024 5.000 put

February 29, 2024 | globenewswire.com

Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting

See More Headlines

Receive OCEA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:OCEA
CUSIP: N/A
CIK: 1836612
Web: N/A
Phone: 646-908-2658
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $17.63
High Stock Price Target: $17.63
Low Stock Price Target: $17.63
Potential Upside/Downside: +887.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($2.26) per share
Price / Book: -0.79

Miscellaneous

Outstanding Shares: 34,070,000
Free Float: 9,030,000
Market Cap: $60.81 million
Optionable: Optionable
Beta: 1.30

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

OCEA Stock Analysis - Frequently Asked Questions

Should I buy or sell Ocean Biomedical stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ocean Biomedical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OCEA shares.
View OCEA analyst ratings or view top-rated stocks.
What is Ocean Biomedical's stock price target for 2024?: 1 brokerages have issued twelve-month target prices for Ocean Biomedical's stock. Their OCEA share price targets range from $17.63 to $17.63. On average, they predict the company's share price to reach $17.63 in the next twelve months. This suggests a possible upside of 887.7% from the stock's current price.
View analysts price targets for OCEA or view top-rated stocks among Wall Street analysts.
When did Ocean Biomedical IPO?: Ocean Biomedical (OCEA) raised $22 million in an initial public offering on the week of April 18th 2022. The company issued 2,000,000 shares at a price of $10.00-$12.00 per share. Roth Capital Partners and JonesTrading served as the underwriters for the IPO.

This page (NASDAQ:OCEA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ocean Biomedical (OCEA) Stock Price, News & Analysis

Ocean Biomedical MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Consensus Rating

Amount of Analyst Coverage

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Dividend Yield

Dividend Growth

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Insiders

Percentage Held by Institutions

Earnings and Valuation

About Ocean Biomedical

OCEA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Competitors

Institutional Ownership

OCEA Stock Analysis - Frequently Asked Questions

Overall MarketRank^™